EP2825201A4 - Bactériophage filamenteux utilisé comme modulateur de l'angiogénèse - Google Patents

Bactériophage filamenteux utilisé comme modulateur de l'angiogénèse

Info

Publication number
EP2825201A4
EP2825201A4 EP13761938.3A EP13761938A EP2825201A4 EP 2825201 A4 EP2825201 A4 EP 2825201A4 EP 13761938 A EP13761938 A EP 13761938A EP 2825201 A4 EP2825201 A4 EP 2825201A4
Authority
EP
European Patent Office
Prior art keywords
angiogenesis
modulator
filamentous bacteriophage
filamentous
bacteriophage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP13761938.3A
Other languages
German (de)
English (en)
Other versions
EP2825201A1 (fr
Inventor
Beka Solomon
Eyal Dor-On
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ramot at Tel Aviv University Ltd
Original Assignee
Ramot at Tel Aviv University Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ramot at Tel Aviv University Ltd filed Critical Ramot at Tel Aviv University Ltd
Publication of EP2825201A1 publication Critical patent/EP2825201A1/fr
Publication of EP2825201A4 publication Critical patent/EP2825201A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/14011—Details ssDNA Bacteriophages
    • C12N2795/14111—Inoviridae
    • C12N2795/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/14011—Details ssDNA Bacteriophages
    • C12N2795/14111—Inoviridae
    • C12N2795/14132—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/14011—Details ssDNA Bacteriophages
    • C12N2795/14111—Inoviridae
    • C12N2795/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2795/14145—Special targeting system for viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/14011—Details ssDNA Bacteriophages
    • C12N2795/14111—Inoviridae
    • C12N2795/14151—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP13761938.3A 2012-03-15 2013-03-15 Bactériophage filamenteux utilisé comme modulateur de l'angiogénèse Withdrawn EP2825201A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261611297P 2012-03-15 2012-03-15
US201261715634P 2012-10-18 2012-10-18
PCT/US2013/032043 WO2013138716A1 (fr) 2012-03-15 2013-03-15 Bactériophage filamenteux utilisé comme modulateur de l'angiogénèse

Publications (2)

Publication Number Publication Date
EP2825201A1 EP2825201A1 (fr) 2015-01-21
EP2825201A4 true EP2825201A4 (fr) 2015-12-09

Family

ID=49161851

Family Applications (1)

Application Number Title Priority Date Filing Date
EP13761938.3A Withdrawn EP2825201A4 (fr) 2012-03-15 2013-03-15 Bactériophage filamenteux utilisé comme modulateur de l'angiogénèse

Country Status (2)

Country Link
EP (1) EP2825201A4 (fr)
WO (1) WO2013138716A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201700009270A1 (it) * 2017-01-27 2018-07-27 Consiglio Naz Delle Ricerche Cnr Coniugati fagici e loro usi
KR20220069102A (ko) 2019-10-01 2022-05-26 어댑티브 페이지 테라퓨틱스, 인크. 박테리오파지 입자의 정제 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5096169B2 (ja) * 2005-02-01 2012-12-12 ラモット・アット・テルアビブ・ユニバーシティ アミロイド沈着に付随する炎症および活性化されたマイクログリアにかかわる脳の炎症の処置法
WO2006095345A2 (fr) * 2005-03-08 2006-09-14 Ramot At Tel-Aviv University Ltd. Bacteriophages transportant des medicaments cibles
WO2007053542A2 (fr) * 2005-11-01 2007-05-10 Boston Life Sciences, Inc. Procedes et compositions pour prevenir et reduire une neovascularisation
MX2008010612A (es) * 2006-02-15 2009-03-20 Ramot At Tel Aviv University Bacteriofago filamentoso que exhibe proteina a como aglutinante de anticuerpos e inmunocomplejos para el suministro hacia el cerebro.
GB0703369D0 (en) * 2007-02-21 2007-03-28 Health Prot Agency Compositions Comprising Capsular Polysaccharides and Their Use as Vaccines

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
BORATYNSKI JANUSZ ET AL: "Preparation of endotoxin-free bacteriophages", CELLULAR & MOLECULAR BIOLOGY LETTERS, UNIVERSITY OF WROCAW. INSTITUTE OF BIOCHEMISTRY, WROCAW; PL, PL, vol. 9, no. 2, 1 January 2004 (2004-01-01), pages 253 - 259, XP002485107, ISSN: 1425-8153 *
DABROWSKA K ET AL: "Activity of bacteriophages in murine tumor models depends on the route of phage administration", ONCOLOGY RESEARCH, PERGAMON PRESS, NEW YORK, NY, US, vol. 15, no. 4, 1 January 2005 (2005-01-01), pages 183 - 187, XP008120418, ISSN: 0965-0407 *
DABROWSKA KRYSTYNA ET AL: "The effect of bacteriophages T4 and HAP1 on in vitro melanoma migration", BMC MICROBIOLOGY, BIOMED CENTRAL LTD, GB, vol. 9, no. 1, 20 January 2009 (2009-01-20), pages 13, XP021048179, ISSN: 1471-2180, DOI: 10.1186/1471-2180-9-13 *
JESSICA I. LUNDIN ET AL: "Endotoxin and Cancer", ENVIRONMENTAL HEALTH PERSPECTIVES SUPPLEMENTS, vol. 117, no. 9, 1 September 2009 (2009-09-01), US, pages 1344 - 1350, XP055221367, ISSN: 1078-0475, DOI: 10.1289/ehp.0800439 *
PAULINA BUDYNEK ET AL: "Bacteriophages and cancer", ARCHIVES OF MICROBIOLOGY, SPRINGER, BERLIN, DE, vol. 192, no. 5, 16 March 2010 (2010-03-16), pages 315 - 320, XP019798350, ISSN: 1432-072X *
See also references of WO2013138716A1 *
TOURNAIRE R ET AL: "A short synthetic peptide inhibits signal transduction, migration and angiogenesis mediated by Tie2 receptor", EMBO REPORTS, vol. 5, no. 3, 1 January 2004 (2004-01-01), pages 262 - 267, XP002321017, DOI: 10.1038/SJ.EMBOR.7400100 *

Also Published As

Publication number Publication date
EP2825201A1 (fr) 2015-01-21
WO2013138716A1 (fr) 2013-09-19

Similar Documents

Publication Publication Date Title
EP2864479A4 (fr) Modulation de l'expression d'ube3a-ats
EP2940131A4 (fr) Variant d'aav
EP2891033A4 (fr) Fonctionnalité d'icône étendue
DK2872485T3 (da) Asymmetrisk hjælpegruppe
EP2931284A4 (fr) Dioxydes d'iminothiadiazine en tant qu'inhibiteurs de bace
EP2880592A4 (fr) Concordance d'historique de réservoir multiniveau
EP2923700A4 (fr) Promoteur d'expression de l'érythropoïétine
EP2908351A4 (fr) Réseau de photodiodes
EP2772021A4 (fr) Autoprotection d'un réseau
FR2985882B1 (fr) Complexe textile d'irrigation
FR2985500B1 (fr) Configuration d'helicoptere
EP2810149A4 (fr) Hiérarchisation intelligente d'extensions activées
EP2539439A4 (fr) Modulation de l'angiogenèse
EP2776564A4 (fr) Modulation de l'expression de tmprss6
EP2802525A4 (fr) Grue télescopique de camera
EP2754862A4 (fr) Gicleur d'huile
EP2910028A4 (fr) Filtrage d'un flux de contenu
EP2925661A4 (fr) Grue
BR302012006076S1 (pt) "configuração construtiva aplicada à barbatana"
EP2909160A4 (fr) Halogénation d'hydrocarbures
EP2847717A4 (fr) Architecture d'intelligence sociale
BR302012005032S1 (pt) " configuração aplicada em sutiã "
FR2994330B1 (fr) Appareil actionneur de type auxiliaire d'un appareil de protection de ligne
BR302012004278S1 (pt) "configuração aplicada à cápsulas"
EP2754451A4 (fr) Utilisation d'ache comme nucléase

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20140902

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
RA4 Supplementary search report drawn up and despatched (corrected)

Effective date: 20151106

RIC1 Information provided on ipc code assigned before grant

Ipc: C12N 7/00 20060101ALI20151102BHEP

Ipc: A61K 39/395 20060101AFI20151102BHEP

Ipc: A61P 35/00 20060101ALI20151102BHEP

Ipc: A61K 35/76 20150101ALI20151102BHEP

Ipc: C07K 14/005 20060101ALI20151102BHEP

Ipc: A61P 31/00 20060101ALI20151102BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20170202